Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Zelman & Assoc Initiates Coverage On Fortune Brands with Hold Rating

Zelman & Assoc Initiates Coverage On Fortune Brands with Hold Rating

Zelman & Assoc initiates coverage on Fortune Brands (NYSE:FBIN) with a Hold rating.

byBenzinga Newsdesk

December 16, 2022

1 minute read

Zelman & Assoc initiates coverage on Fortune Brands (NYSE:FBIN) with a Hold rating.

Analyst Ratings

What 6 Analyst Ratings Have To Say About Instil Bio

By Benzinga Insights

November 17, 12:05 PM

Analysts have provided the following ratings for Instil Bio (NASDAQ:TIL) within the last quarter: Bullish Somewhat Bullish Indifferent…

TIL

Analyst Ratings

Analyst Scoreboard: 8 Ratings For Welltower

By Benzinga Insights

January 30, 11:00 AM

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Welltower (NYSE:WELL)…

WELL

Meta Paid Bright Data to Scrape Information From Other Websites While Banning The Practice From Its Own Site

By Charles Gross

February 2, 5:46 AM

-Bloomberg https://www.bloomberg.com/news/articles/2023-02-02/meta-was-scraping-sites-for-years-while-fighting-the-practice?srnd=technology-vp&sref=y3YMCJ4e&leadSource=uverify%20wall

Director Yu Soo Buys 44,895 Shares Of Aikido Pharma At An Average Price Of $6.33; Director Kyle Wool Buys 36,295 Shares Of Aikido Pharma At An Average Price Of $6.33

By Benzinga Newsdesk

September 14, 11:32 AM

- SEC Form4 Filing

AIKI

Zelman & Assoc Initiates Coverage On Fortune Brands with Hold Rating

Related Posts

What 6 Analyst Ratings Have To Say About Instil Bio

Analyst Scoreboard: 8 Ratings For Welltower

Meta Paid Bright Data to Scrape Information From Other Websites While Banning The Practice From Its Own Site

Director Yu Soo Buys 44,895 Shares Of Aikido Pharma At An Average Price Of $6.33; Director Kyle Wool Buys 36,295 Shares Of Aikido Pharma At An Average Price Of $6.33